OneSkin

Agetech’s chance to be the new fintech

Latest articles

Exclusive video interview with Erin Sharoni of JUVICELL

We talk fasting, lifespan and longevity supplements with JUVICELL's co-founder, Erin Sharoni. Recently, we were excited to cover the launch of brand-new longevity supplement JUVICELL,...

Longevity supplement innovator soft-closes $5.5m

Ponce de Leon: the longevity supplement company behind Rejuvant could raise up to $15m in current series B round. Ponce de Leon Health, a company...

Swiss longevity company builder launches

Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice. Already touted as a hotbed of longevity innovation, Switzerland is...

New aging clock is a key longevity tool

A new aging clock that's close to the theoretical limit of accuracy boasts unprecedented precision and offers new insights into how the aging process...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Apollo Neuro

Editor's picks

Exclusive video interview with Erin Sharoni of JUVICELL

We talk fasting, lifespan and longevity supplements with JUVICELL's co-founder, Erin Sharoni. Recently, we were excited to cover the launch of brand-new longevity supplement JUVICELL,...

Longevity supplement innovator soft-closes $5.5m

Ponce de Leon: the longevity supplement company behind Rejuvant could raise up to $15m in current series B round. Ponce de Leon Health, a company...

Swiss longevity company builder launches

Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice. Already touted as a hotbed of longevity innovation, Switzerland is...
OneSkin

Inside the UK business community’s mission to become a leader in Agetech.

UK business leaders gathered in the City yesterday to discuss the development of products and services that facilitate better aging at the launch of the Longevity Leaders World Congress running in London, 21-22 April 2020.

Parallels have been drawn between the fledgling Agetech sector and the now booming Fintech sector of five years ago. Since 2014, the UK’s Fintech investment market has grown from $0.2bn USD to $3bn USD, compared with $36bn USD invested globally. Some might argue that the UK missed out on really making a global impact in Fintech. With Agetech projected to become a multi-trillion dollar economy, stakeholders are banking on early innovation, ambitious investment and government support to put the UK at its forefront.

“Today Agetech globally is about $1 trillion a year in revenue of which at least 50% is generated by powerful digital firms such as Amazon and Apple,” said Dominic Endicott, founding partner, 4GEN Ventures. “It will double to $2 trillion by 2025. UK Agetech start-ups already generate around £400m in revenue, but as the wave unfolds, we believe this could grow to £5bn in 2025. UK firms will also be in prime position to later grow into large markets such as the US, where Agetech revenue in 2025 could pass $35bn.”

Rather than focusing on the stereotype of elderly people without agency or purpose, the focus of the Longevity Leaders World Congress is on aging as a positive and proactive process, which some of the UK’s most prominent companies are looking to facilitate.

“Supporting our growing aging population and looking after the financial wellbeing of younger generations to come is one of the most important issues of the future,” said Elisabeth Bremner, a partner in the Financial Services Regulatory team at law firm CMS. “With the next generation of retirees poorly prepared for later life costs, shortfalls in social care spending and failings in government policy, the once hoped for expectation that parents would pass on a legacy to their children is weakening. Money flows are shifting into reverse as children help fund the needs of their ageing parents and face disruptions in working patterns to help provide care; stalling their own hopes and aspirations.”

Inside the UK business community’s mission to become a leader in Agetech.

Consulting firm Mercer has created the Next Age Next Stage program, which sets out a vision for how older workers can be beneficial to companies and why it’s important that businesses should retain, retrain and recruit older employees. With a growing elderly population, Mercer believes it is imperative that new structures be put into place to allow individuals to work beyond the traditional retirement age. This provides a way for people to stay financially healthy, as well as making sure they maintain a sense of purpose and community.

“Longevity poses one of the biggest challenges of our time in relation to the impact on work, workers and workplace,” said Yvonne Sonsino, Innovation Leader at Mercer. “Combined with 4IR style automation and its associated impact in the same sphere, this is an incredibly exciting time to be working with employers to work out how to embrace longevity to ensure their businesses thrive as a result of getting it right.”

Vodafone is working on harnessing technology to tackle loneliness. The company analysed the economic cost that isolation brings among people over 50 years old and discovered an annual cost of £1.8bn to the UK economy. Vodafone focused on how to better understand technology and its uses in reducing loneliness and promoting an active lifestyle, and is now working on a series of programs to improve day-to-day use of technology for people over 50.

The launch event showed that it isn’t just the big companies who see the opportunity to serve the UK’s aging population. Also present were a host of start-up entrepreneurs, including companies like Chronomics, Kemuri, and Zone V, who are developing tools to help individuals manage their own health and financial wellness, as well as protect their assets, establish online and physical communities, and integrate technology seamlessly into their lives.

The financial opportunity presented by the sector was reflected by the attendance of a wide range of investors, including VCs, angel investors and corporate venture teams. Their presence brings up an important question: could the UK become the world’s Agetech hub?

The Longevity Leaders World Congress takes place in London, 21-22 April 2020.

 Image: IR Stone / Shutterstock.com
Salvinija Roznyte
Staff Writer Salvinija Roznyte is a writer and journalist based in London. She graduated in 2018 with a Bachelor's degree majoring in Writing and Journalism with a minor in Film Studies. She is interested in the way modern medical technology changes and shapes our world.
OneSkin

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...

NAD+ and metformin: AgelessRx’s anti-aging platform

Personalised longevity medicine is the top goal for AgelessRx. In November we spoke to Anar Isman, the Co-founder & CEO of AgelessRx, about PEARL, the...
Apollo Neuro

Related articles

Longevity supplement innovator soft-closes $5.5m

Ponce de Leon: the longevity supplement company behind Rejuvant could raise up to $15m in current series B round. Ponce de Leon Health, a company...

Swiss longevity company builder launches

Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice. Already touted as a hotbed of longevity innovation, Switzerland is...

Elastrin limbers up for success with Kizoo funding boost

Kizoo provides seed funding for Elastrin Therapeutics to develop ground-breaking new technology capable of reversing tissue and organ calcification. It was announced today that Elastrin,...

Targeting longevity risk management

Vesttoo harnesses the power of AI for data-driven management of longevity risk. Israel-based start-up Vesttoo has developed a set of data-driven risk management solutions for...

AgeX and LyGenesis to negotiate merger agreement

The biotech merger between AgeX and LyGenesis will neaten-up Juvenescence's portfolio. AgeX Therapeutics, a biotech developing therapeutics for human aging and cell regeneration, and LyGenesis,...
OneSkin